MYCimmune is an international cancer research and innovation collaborative, which strives to advance clinically viable MYC oncogene-directed therapeutic concepts to early phase clinical testing. In essence, the concept of synthetic lethality follows the same principles as one of the most popular martial art Judo – instead of trying to subdue the force of your adversary with even mightier force, you just use the strength of your adversary as a weapon against itself.